Codes / ICD10CM / T65.832S

T65.832S Toxic effect of fiberglass, intentional self-harm, sequela

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Toxic Effect of Fiberglass, Intentional Self-Harm, Sequela (ICD-10-CM Code: T65.832S)

Summary

This condition describes residual or late effects resulting from intentional self-harm involving fiberglass exposure. It encompasses persistent health issues that develop after the acute phase of toxicity, including chronic skin, respiratory, or ocular complications. The sequela may arise from prolonged irritation, scarring, or ongoing inflammation following deliberate exposure to fiberglass particles.

Causes

The toxic effect originates from intentional self-harm involving fiberglass, with sequela developing as a consequence of the initial exposure. Fiberglass, a synthetic material used in insulation and industrial products, can cause mechanical or chemical irritation when inhaled or contacted. The sequela reflects lasting damage from this deliberate exposure, such as chronic dermatitis, respiratory impairment, or ocular scarring.

Risk Factors

  • Deliberate exposure to fiberglass in a self-harm context.
  • Lack of protective measures during intentional handling.
  • Pre-existing conditions that may worsen long-term effects (e.g., asthma, sensitive skin).
  • Inadequate initial treatment or delayed care for the acute exposure.

Symptoms

  • Chronic skin reactions: persistent itching, scarring, or thickened skin (lichenification).
  • Respiratory issues: ongoing cough, wheezing, or reduced lung function.
  • Eye problems: dryness, scarring, or recurrent irritation.
  • Generalized symptoms: fatigue or sensitivity to fiberglass exposure.

Diagnosis

Diagnosis involves reviewing the history of intentional self-harm with fiberglass exposure and identifying persistent symptoms beyond the acute phase. Clinical evaluation may include physical exams to assess skin, respiratory, or ocular changes. Diagnostic tests, such as pulmonary function tests or skin biopsies, may be used to confirm chronic effects. Documentation must link the sequela to the prior intentional exposure.

Treatment Options

Treatment focuses on managing chronic symptoms and preventing further exposure. This may include topical corticosteroids for skin irritation, bronchodilators or inhaled steroids for respiratory issues, and lubricating eye drops for ocular symptoms. Long-term care may involve specialist referrals (e.g., dermatology, pulmonology) and protective measures to avoid re-exposure.

Prognosis and Follow-Up

Prognosis depends on the severity of initial exposure and the effectiveness of treatment. Chronic symptoms may persist but can often be managed with ongoing care. Regular follow-up is recommended to monitor for worsening symptoms or new complications. Addressing underlying mental health concerns is critical to prevent recurrence.

Complications

  • Chronic respiratory conditions (e.g., asthma, bronchitis).
  • Permanent skin scarring or discoloration.
  • Ocular damage leading to vision impairment.
  • Increased sensitivity to future fiberglass exposure.

Lifestyle & Prevention

  • Avoid further contact with fiberglass to prevent symptom exacerbation.
  • Use protective equipment (gloves, masks, goggles) if exposure is unavoidable.
  • Maintain good skin and respiratory hygiene to reduce irritation.
  • Seek mental health support to address self-harm behaviors and reduce recurrence risk.

When to Seek Professional Help

Consult a healthcare provider if chronic symptoms worsen, new symptoms develop, or if there is difficulty managing daily activities due to persistent effects. Emergency care is needed for severe respiratory distress, eye injury, or signs of infection.

Tips for Medical Coders

Use T65.832S for sequela of intentional self-harm involving fiberglass. Document the link between the prior intentional exposure and the current chronic effects. Ensure the sequela is clearly attributed to the original toxic effect, with details on the nature and duration of residual symptoms.

Book a walkthrough

T65.832S policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.